This is the authors' abstract. We don't add key points for this paper.
The NCCN Guidelines for Biliary Tract Cancers (BTCs) provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts is convened at least once annually to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. This manuscript focuses on the adjuvant chemotherapy and chemoradiation treatment options for BTCs as well as the systemic treatment recommendations for patients with advanced BTCs.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Benson et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: